BioSpace News Archive

Business

Peter Ferdinandy “Highly-Cited Researcher” 2017

Based on the most frequently cited publications between 2005 and 2015 altogether 3300 researchers were recognized from all over the world in 21 various scientific disciplines.

December 4, 2017

·

1 min read

Business

Dance Biopharm and Phillips-Medisize Enter Into Joint Development Agreement for Advanced Inhaled Insulin Delivery

Dance has awarded Phillips-Medisize the development work associated with future enhancements to Dance’s devices as well as the commercial manufacturing of Dance’s inhaled insulin device when it comes to market.

December 4, 2017

·

5 min read

Drug Development

La Jolla Pharmaceutical Company Announces Initiation of Pivotal Clinical Study of LJPC‑401 in Patients With Beta Thalassemia

LJ401-BT01 is a pivotal, multinational, multicenter, randomized, controlled study that is designed to enroll approximately 100 patients across 9 countries.

December 4, 2017

·

6 min read

Mettler Toledo’s Lab Expertise Library Offers White Papers, Webinars, and More

he Lab Expertise Library offers users a wealth of ideas and tips on a wide range of topics.

December 4, 2017

·

1 min read

Business

Novelion Therapeutics Appoints Michael Price as Senior Vice President and Chief Financial Officer

Gregory Perry has resigned as CFO of Novelion to pursue other opportunities, and will remain with the Company until December 31, 2017 to enable an effective transition.

December 4, 2017

·

4 min read

Business

Mustang Bio Announces License Agreement With Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T Therapies

Under the deal, technologies related to the development of off-the-shelf CAR T, as well as CRISPR/Cas9 gene editing platforms, will be utilized in conjunction with Mustang’s CAR T cell therapies.

December 4, 2017

·

4 min read

Business

Marrone Bio Innovations Adds Three Commercial Managers for Southeast, West Coast, and Northeast and Mid-Atlantic Regions

As seasoned experts in discovering, developing and commercializing naturally derived technologies, MBI has created an industry leading platform of pest management and plant health products.

December 4, 2017

·

5 min read

Drug Development

Risankizumab Meets All Primary Endpoints Reporting Positive Results in it’s Fourth Pivotal Phase III Psoriasis Study

Results from the first phase showed that after 16 weeks of treatment, risankizumab met the co-primary endpoints of at least a 90 percent improvement in the Psoriasis and Severity Index.

December 4, 2017

·

14 min read

Drug Development

Zogenix Announces New Positive Efficacy and Safety Data from Pivotal Phase III Clinical Trial of ZX008 in Dravet Syndrome

The updated Study 1 results, as well as additional data supporting the further investigation of ZX008 in refractory epilepsies, were presented at the 71st American Epilepsy Society Annual Meeting.

December 4, 2017

·

9 min read

Drug Development

XBiotech Announces Publication of Phase II Data From Hidradenitis Suppurativa Phase II Study in The Journal of Investigative Dermatology

The publication highlights the efficacy of MABp1, in which the study’s primary endpoint was met in 60% of MABp1 treated patients compared to 10% of placebo patients.

December 4, 2017

·

5 min read